Yposkesi, an SK pharmteco company
Created in 2016
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
377 9,732Activities
Technologies
Entity types
Location
20 Rue Henri Auguste Desbruères, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 51-200
Estimated: 174
SIREN
815409503Engaged corporates
18
4 15Added in Motherbase
5 years, 2 months ago
deeptech Value proposition
Partnering to bring your cell and gene therapies to life!
***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.***
Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing.
As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi operates multiple manufacturing suites for bulk drug substances (up to 1,000 L) and fill and finish to support the growing demand for late-phase projects. In 2023, Yposkesi will bring online additional capacity by increasing its global footprint to 100,000 ft2 (approx. 10,000 m2) with a second large-scale facility designed for EMA and FDA compliance.
Yposkesi’s investment in innovation ensures that its bioprocessing platforms deliver high-quality gene-modified cell therapies and in vivo gene therapy projects.
Yposkesi’s staff of ~200 employees is located on the Genopole Campus in Corbeil-Essonnes (South of Paris), France.
• Bioprocess development (USP & DSP), • GMP manufacturing of clinical and commercial batches, • Analytical development, assays qualification & validation, • Fill & Finish, and • Regulatory supportOriginal language
Partnering to bring your cell and gene therapies to life!
***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.***
Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing.
As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi operates multiple manufacturing suites for bulk drug substances (up to 1,000 L) and fill and finish to support the growing demand for late-phase projects. In 2023, Yposkesi will bring online additional capacity by increasing its global footprint to 100,000 ft2 (approx. 10,000 m2) with a second large-scale facility designed for EMA and FDA compliance.
Yposkesi’s investment in innovation ensures that its bioprocessing platforms deliver high-quality gene-modified cell therapies and in vivo gene therapy projects.
Yposkesi’s staff of ~200 employees is located on the Genopole Campus in Corbeil-Essonnes (South of Paris), France.
Yposkesi | European CDMO in gene therapy & viral vector manufacturing - Yposkesi
Yposkesi is a French-based CDMO offering bioprocess development and cGMP manufacturing services for AAV and lentiviral vector production.
https://www.yposkesi.com/?utm_source=linkedin%20company%20page%20description&utm_medium=social&utm_campaign=linkedin%20company%20page%20description
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Capitalistic Partnership Not event 22 Jul 2020 | | |
 Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Jul 2020 | | |
 PharmaTimes Media Ltd Pharmaceutical, Pharmaceutical Manufacturing | PharmaTimes Media Ltd Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 15 Oct 2020 | | |
 Biogen Biotechnology, Biotechnology Research | Biogen Biotechnology, Biotechnology Research | Not capitalistic Partnership Not event 14 Oct 2020 | | |
 Alexion Pharmaceuticals, Inc. Pharmaceutical, Biotechnology, Biotechnology Research | Alexion Pharmaceuticals, Inc. Pharmaceutical, Biotechnology, Biotechnology Research | Capitalistic Not partnership Not event 15 Dec 2020 | | |
 Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Not capitalistic Partnership Not event 2 Feb 2021 | | |
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Not capitalistic Partnership Event 16 Dec 2020 24 Jul 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 6 May 2022 28 Mar 2024 | | |